Necrotising enterocolitis: To PCT or not to PCT?
A national survey of all 24 national neonatal surgical centres explored preventive strategies for necrotising enterocolitis (NEC). Particular focus was given to the use of procalcitonin (PCT) in other centres, given that Leeds neonatal units have been at the forefront of incorporating the biomarker into sepsis detection and antimicrobial stewardship. National adoption remains limited. Evidence suggests that early elevation of PCT levels may differentiatie surgical from medical NEC and improve diagnostic accuracy when combined with other markers, supporting its potential as an early biomarker of NEC severity.
Erin FrankelMedical student
Sydnie Harris-Campbell
Medical student
School of Medicine, University of Leeds
Dr Nicola Mullins
Neonatal Consultant
Dr Liz McKechnie
Neonatal Consultant
Dr Ourania Pappa
Post CCT Neonatal SPIN Trainee (2)
ourania.pappa@nhs.net
Leeds Centre for Newborn Care, Leeds Children’s Hospital
Frankel E., Harris-Campbell S., Mullins N., McKechnie L., Pappa O. Necrotising enterocolitis: To PCT or not to PCT? Infant 2025; 21(6): 174-78.
Please subscribe and log in to see the full article.
- The underlying mechanisms that lead to NEC are not completely understood.
- NEC is a gastrointestinal disease with a 5-12% incidence in the UK.
- Determining accurate predictors of early NEC pathology has been notoriously problematic.
Also published in Infant:
